Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Paola Pimentel-Cáceres"'
Autor:
Paola Pimentel-Cáceres, Antonio Andrés Rueda-Ramos, Begoña Soler-López, Julio José Lambea-Sorrosal, Mª Paola García-Coves, Antonio Javier Jiménez-López, Lara Iglesias-Docampo, Juan Antonio Núñez-Sobrino, Ana Cabezón-Álvarez, Iker López-Calderero, José Luis Firvida-Pérez
Publikováno v:
Open Journal of Pain Medicine. :009-014
Background: During the oncological disease, patients may suffer a special type of pain called breakthrough pain (BTP), defined as a transient exacerbation of pain that occurs either spontaneously, or in relation to a specific predictable or unpredict
Autor:
Miguel Angel A. Climent Duran, Jose Luis Perez-Gracia, Jose Angel Arranz Arija, Carlos Alvarez-Fernandez, Jenifer Gomez Mediavilla, Angel Rodriguez, Sergio Vazquez-Estevez, Jose Miguel Jurado, Carmen Santander, Teresa Bonfill, Carmen Molins Palau, Sara Perez Ramirez, Paola Pimentel Cáceres, Pablo Arnáiz, Zita Garate, Atenea Soto, Javier Puente
Publikováno v:
Journal of Clinical Oncology. 40:484-484
484 Background: Atezolizumab is a monoclonal antibody with proven efficacy in clinical trials for advanced or metastatic urothelial carcinoma (UC) after progression to platinum-based chemotherapy. Following EMA marketing authorization and before priz
Autor:
Jorge Muñoz Luengo, Ariadna Lloansí Vila, Juan J. Cruz-Hernández, Jose María Vieitez, Marta Llanos, L. Cirera, Pilar Alfonso, Carlos Garcia Giron, Manuel Valladares-Ayerbes, Paola Pimentel Cáceres
Publikováno v:
Journal of Clinical Oncology. 36:e15602-e15602
e15602Background: Tumor biopsies are widely used in clinical practice to assess RAS mutation status in mCRC patients. However, new techniques of genotyping based on circulating tumor (ct) DNA prese...